Ventinova

What Ventinova does

Ventinova Medical, founded in 2013 in the Netherlands with commercial operations through its Spanish subsidiary IES Medical SL, develops and markets medical devices for airway management and mechanical ventilation based on proprietary Flow-Controlled Ventilation (FCV) technology. The product portfolio comprises four core devices: Evone, the only mechanical ventilator providing full control of both inspiratory and expiratory phases via FCV; Ventrain, a single-use manual ventilator using the Venturi principle for active inspiration and active expiration through small-bore lumens; Tritube, an ultrathin endotracheal tube with less than 3 mm internal diameter; and Cricath, a 2 mm cricothyrotomy catheter for emergency front-of-neck access. The company complements its hardware with Ventinova Academy, a free online learning platform launched in November 2025 that delivers FCV training and clinician certification.

Ventinova monetizes exclusively through hardware sales (capital equipment and single-use consumables) distributed via exclusive regional distributors across 18+ countries spanning Western, Northern, Southern, and Eastern Europe, the Middle East (Israel, Qatar), and North America (USA). Its primary customers are tertiary-care hospitals performing ENT/laryngeal, thoracic, abdominal, and robotic-assisted surgeries, ICUs treating difficult airways, and emergency-medicine teams managing CICO scenarios. The company supports adoption through ten reference hospitals (Radboud UMC, Rigshospitalet, UZ Leuven, Hôpitaux Universitaires Genève, Hamad Medical Corporation, Hacettepe, and others) that serve as clinical demonstration sites, and through sustained participation in medical conferences (MEDICA, WAMM, SIMUVAD, SEMES).

The business is privately held, holds ISO 13485:2016, ISO 9001, ISO 14001, and ISO 45001 certifications, and has been funded primarily through European and Dutch public grants (EU Horizon 2020, European Regional Development Fund, Dutch Ministry of Economic Affairs Innovation Credit) along with a ~$2.69M European Innovation Council grant in 2020 and earlier rounds led by BOM and Holland Capital. The core technology is based on patents developed by Prof. Dr. Dietmar Enk, with clinical and scientific advisory support from Prof. emer. Tom Barnes.

Name

Ventinova

Legal name

International Emergency Services, S.L. (IES MEDICAL)

Website

https://ventinovamedical.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Ventinova Medical develops and markets proprietary Flow-Controlled Ventilation (FCV) medical devices—Evone, Ventrain, Tritube, and Cricath—for hospitals performing complex airway, ENT, thoracic, and emergency ventilation procedures, distributing through exclusive partners in 18+ countries.

Ownership category

akta.pro rank

Product category

Mechanical Ventilation and Airway Management Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)

akta.pro secondary industries

Airway Management Devices (ET Tubes, LMAs, Tracheostomy, Suction) (HLAHAGAF), Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers) (HLAHAGAK)

Keywords

• Mechanical ventilation devices
• Airway management equipment
• Flow-controlled ventilation
• Endotracheal tubes
• Emergency airway access

Headquarters

HQ city

Eindhoven

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Medical Device Sales: Ventinova Medical generates revenue through the sale of proprietary medical devices including Evone mechanical ventilators, Ventrain manual ventilators, Tritube ultrathin endotracheal tubes, and Cricath cricothyrotomy catheters. All products are sold through a global distributor network and directly to healthcare institutions.

Go-to-market motion2 records

Distribution channels15 records

Marketing channels9 records

Core offering

Ventinova Medical develops, manufactures, and sells a portfolio of patented airway management and ventilation devices based on proprietary Flow-Controlled Ventilation (FCV) technology. The portfolio includes Evone (the only mechanical ventilator providing full control of both inspiratory and expiratory phases), Ventrain (single-use manual ventilator using the Venturi principle for ventilation through small-bore lumens), Tritube (ultrathin endotracheal tube with internal diameter under 3 mm), and Cricath (2 mm cricothyrotomy catheter for emergency front-of-neck access in CICO situations). These are sold to hospitals, surgical teams, ICUs, and emergency medicine providers through an exclusive global distributor network spanning 18+ countries.

Product overview

Ventinova Medical offers a portfolio of medical devices based on proprietary Flow-Controlled Ventilation (FCV®) technology. The core portfolio includes Evone®, a mechanical ventilator providing full control of both inspiratory and expiratory phases; Ventrain®, a single-use manual ventilation device; Tritube®, an ultrathin endotracheal tube with less than 3 mm ID; and Cricath®, a 2 mm cricothyrotomy catheter for emergency airway access. These products work together as an integrated ventilation system, with Evone and Ventrain serving as the primary ventilation sources compatible with Tritube and Cricath as access devices. The company also offers Ventinova Academy, a free online learning platform providing courses and certification on FCV technology.

Differentiator

Problem solved

Functional benefit

Brands

• Ventinova Academy: Free online learning platform for FCV technology education, featuring courses, webinars, and certification programs for healthcare professionals on ventilation and airway management.
• FCV Technology

Products and services

• Evone® Mechanical Ventilator The only mechanical ventilator providing Full Control Ventilation (FCV) of the entire ventilatory cycle, with full control of both inspiratory and expiratory phases in anesthetized patients. Includes four ventilator settings (End-expiratory pressure, Peak pressure, Inspiration Flow, I:E ratio), a conventional tube adapter for standard endotracheal tubes (5-10 mm ID), and an optional High Frequency Jet Ventilation mode. Designed for hospitals and anesthesia teams performing ENT/laryngologic surgery, thoracic surgery, and ICU ventilation.
• Ventrain® Manual Ventilator Single-use hand-held manual ventilation device using FCV technology and the Venturi principle to provide active inspiration and active expiration through any narrow bore lumen with a Luer connector. Achieves an I:E ratio of 1:1 and minute volume of 7-7.5 L/min. Designed for difficult airway and emergency front-of-neck access ventilation in CICO situations when used with Cricath.
• Cricath® Cricothyrotomy Catheter

Quantifiable outcome

• 53% reduction in energy dissipation vs Pressure Controlled Ventilation (PCV)
• +4 more outcomes

Named customers10 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered core.

• Radboud University Medical Center (Netherlands)coreStrategic or Co-development PartnerReference hospital using Evone during laryngologic and thoracic surgery. Currently conducting a clinical study on FCV ventilation. Independent medical specialists willing to share experience and demonstrate clinical use.
• Rigshospitalet (Denmark)coreStrategic or Co-development PartnerReference hospital using Evone mainly during laryngologic surgery. Evone and Tritube are included in Airway management workshops. A randomized controlled trial has been executed and another study being planned.
• University Hospital Leuven / UZ Leuven (Belgium)coreStrategic or Co-development PartnerReference hospital using Evone during laryngologic and thoracic surgery. Clinical study being planned.
• Hamad Medical Corporation (Qatar)coreStrategic or Co-development PartnerReference hospital using Evone mainly during laryngologic surgery and other procedures. Included Evone in their training programs and hosts trainees from Middle East and Gulf Area inside Simulation Center and operating theatre for clinical demonstrations.
• Hôpitaux Universitaires Genève (Switzerland)coreStrategic or Co-development PartnerReference hospital using Evone during laryngologic, abdominal and thoracic surgery. Clinical study being planned.
• IES Medical SL (Spain)coreChannel Partner/ Reseller/ DistributorManufacturer and exclusive distributor for Spain. Parent company of Ventinova brand. Represents Ventinova at international exhibitions (MEDICA, WAMM, SEMES). Hosts Ventinova Academy platform. Contact: +34 94 400 88 47.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Intersurgical: European manufacturer of airway management devices, breathing circuits, and ventilation accessories. Comparable to Ventinova in being a focused, niche airway/respiratory specialist selling into European hospitals through distribution.
• Hamilton Medical: Swiss manufacturer of intelligent mechanical ventilators (e.g., HAMILTON-C1, G5) widely used in OR and ICU. Direct competitor to Evone in mechanical ventilation, with overlapping clinical positioning around lung-protective ventilation and high-acuity hospital use cases.
• Vyaire Medical: Pure-play respiratory company offering mechanical ventilators (Bellavista, fabian) and consumables across ICU, NICU, and OR. Direct competitor to Evone and to Tritube/Ventrain consumables, focused exclusively on ventilation and airway management.
• Teleflex: Specialist in airway management (LMA, Rusch, Arrow endotracheal tubes) and emergency cricothyrotomy devices. Direct competitor to Tritube and Cricath in the difficult-airway and emergency front-of-neck access categories.

Regional players

• ResMed: Global leader in sleep and non-invasive ventilation (Lumis, Stellar) — comparable in lung-protective ventilation philosophy but focused on chronic/home and sleep-medicine settings rather than the OR/ICU difficult-airway segment Ventinova serves.

Broad incumbents

• Medtronic: Diversified medtech giant with a strong airway management portfolio (e.g., Shiley, Mallinckrodt endotracheal tubes, McGrath laryngoscopes). Competes with Tritube in ultrathin/specialized endotracheal tubes and with Cricath in cricothyrotomy catheters.
• Dräger: German manufacturer of anesthesia workstations, ICU ventilators (e.g., Evita, Perseus), and airway devices. Broad incumbent in the same OR and ICU customer base as Ventinova, with overlapping focus on lung-protective ventilation.
• Fisher & Paykel Healthcare: New Zealand-listed respiratory care specialist offering high-flow nasal cannula, humidification, and NIV interfaces. Adjacent competitor to FCV in lung-protective respiratory support and to Tritube's NIV/sealed-airway proposition.
• Getinge: Global medtech incumbent offering Servo ventilators and a broad OR/ICU portfolio. Competes with Evone in hospital mechanical ventilation and with Ventrain in airway/emergency ventilation, but as part of a much larger diversified portfolio.

Emerging players

• Penlon: UK-based anesthesia and ventilation equipment manufacturer (e.g., Prima series anesthesia workstations, ventilators). Comparable niche scale to Ventinova with overlapping OR/anesthesia customer base.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/watch?v=xg4A9TnaKIU
• Xx.com/ventinovamed

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ventinova